Search

everythinglearnresearchcommunity

for

Search:↓

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

A ketogenic diet helps reduce weight, BMI, waist size, and fat in overweight women with PCOS.

Metformin is less effective in men with early-onset hair loss.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

Women with PCOS have higher body fat and skinfold thickness, especially in the H-O-POM phenotype.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Breast cancer patients have lower hair zinc levels, which strongly decrease as BMI increases.

BMI1 is essential for preventing hair greying and maintaining hair color.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Girls with Pilonidal Disease are more likely to have Polycystic Ovarian Syndrome, and treating PCOS may reduce the need for PD intervention.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Polycystic ovary syndrome (PCOS) lowers women's quality of life, especially mentally and socially, but nursing guidelines can improve their understanding of the condition.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Young female athletes should be informed about health risks like menstrual issues and bone problems from excessive sports.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Higher BMI may increase the risk of psoriasis and some other skin diseases.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

The Fatty Liver Index (FLI) may not be enough to rule out non-alcoholic fatty liver disease in lean women with polycystic ovary syndrome.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Scalp hair sweating is a significant predictor of hair cortisol levels.